| | 107868-30-4 Basic information More.. |
| Product Name: | Exemestane | | Synonyms: | ExeMestane (USP);1,4-Androstadien-3,17-dione-6-Methylene-d2;(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione;ExeMestine;(8R,9S,10R,13S,14S)-10,13-diMethyl-6-Methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione;ExeMestane SynonyMs 6-Methylenandrosta-1,4-diene-3,17-dione;PNU155971;Exemestane for system suitability | | CAS: | 107868-30-4 | | MF: | C20H24O2 | | MW: | 296.4 | | EINECS: | 643-090-2 | | Mol File: | 107868-30-4.mol |  |
Use
For patients resistant to tamoxifen, 25mg of Exemestane, qd, can achieve an objective efficacy rate of 15-28% and a median continuation period of 69-76 weeks. Exemestane is superior to Megestrol, and it can extend the disease progression time. For patients who have worsened conditions following Megestrol treatment, Exemestane can still achieve an objective efficacy rate of 11-13%. A daily 25mg dose of Exemestane has an objective efficacy rate of 6.6% on patients who have not responded to non-steroidal aromatase inhibitors, and the two drugs are not cross-resistant.
- ExeMestane(AroMasin)
-
- US $9.90-3489.00 / g
- 2024-04-27
- CAS:107868-30-4
- Min. Order: 1g
- Purity: 99.99%
- Supply Ability: 2 tons
- Exemestane
-
- US $9.90-3489.00 / g
- 2024-04-27
- CAS:107868-30-4
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 100kg
- Exemestane
-
- US $20.00-10.00 / kg
- 2024-04-26
- CAS:107868-30-4
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 20
|
|
107868-30-4
Recommend Suppliers |
|